INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 437m ago
HOUSE PTR36m ago
SEC 13F36m ago
ROBINHOOD CHAIN36m ago
Corporate insider
JL

Johnson Philip L

EVP & Chief Financial OfficerCIK 0002013156

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score19
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$795K
3,343 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Jazz Pharmaceuticals plcEVP & Chief Financial Officer · Mar 2, 2026
15
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F
$493K
2,615 sh
Mar 5, 2026
Mar 9, 2026
traded Mar 5, 2026
+4d
SEC FORM 4

Evidence

17
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
11.9K sh
Feb 26, 2026Mar 2, 2026
traded Feb 26, 2026
+4dSEC FORM 4

Evidence